| Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ... Diabetologia 61 (12), 2461-2498, 2018 | 1844 | 2018 |
| Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis CS Fox, K Matsushita, M Woodward, HJG Bilo, J Chalmers, ... The Lancet 380 (9854), 1662-1673, 2012 | 727 | 2012 |
| Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease … BC Astor, K Matsushita, RT Gansevoort, M Van Der Velde, M Woodward, ... Kidney international 79 (12), 1331-1340, 2011 | 577 | 2011 |
| Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study P Rossing, P Hougaard, K Borch-Johnsen, HH Parving Bmj 313 (7060), 779-784, 1996 | 544 | 1996 |
| Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients MA Gall, P Rossing, P Skøtt, P Damsbo, A Vaag, K Bech, A Dejgaard, ... Diabetologia 34 (9), 655-661, 1991 | 486 | 1991 |
| Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study P Hovind, L Tarnow, P Rossing, M Graae, I Torp, C Binder, HH Parving Bmj 328 (7448), 1105, 2004 | 473 | 2004 |
| Hyperglycemia and the pathobiology of diabetic complications D Aronson Cardiovascular Diabetology: Clinical, Metabolic and Inflammatory Facets 45, 1-16, 2008 | 442 | 2008 |
| Progression of nephropathy in type 2 diabetic patients K Rossing, PK Christensen, P Hovind, L Tarnow, P Rossing, HH Parving Kidney international 66 (4), 1596-1605, 2004 | 417 | 2004 |
| Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes P Hovind, L Tarnow, K Rossing, P Rossing, S Eising, N Larsen, C Binder, ... Diabetes care 26 (4), 1258-1264, 2003 | 401 | 2003 |
| Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy S Andersen, L Tarnow, P Rossing, BV Hansen, HH Parving Kidney international 57 (2), 601-606, 2000 | 400 | 2000 |
| Progression of diabetic nephropathy P Hovind, P Rossing, L Tarnow, UM Smidt, HH Parving Kidney international 59 (2), 702-709, 2001 | 398 | 2001 |
| Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis BK Mahmoodi, K Matsushita, M Woodward, PJ Blankestijn, M Cirillo, ... The Lancet 380 (9854), 1649-1661, 2012 | 383 | 2012 |
| 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study … JB Buse, DJ Wexler, A Tsapas, P Rossing, G Mingrone, C Mathieu, ... Diabetes Care 43 (2), 487-493, 2020 | 376 | 2020 |
| Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial GL Bakris, B Pitt, MR Weir, MW Freeman, MR Mayo, D Garza, Y Stasiv, ... Jama 314 (2), 151-161, 2015 | 364* | 2015 |
| Diabetes and hypertension: a position statement by the American Diabetes Association IH De Boer, S Bangalore, A Benetos, AM Davis, ED Michos, P Muntner, ... Diabetes Care 40 (9), 1273-1284, 2017 | 329 | 2017 |
| Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial P Gæde, J Oellgaard, B Carstensen, P Rossing, H Lund-Andersen, ... Diabetologia 59 (11), 2298-2307, 2016 | 324 | 2016 |
| Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study P Rossing, P Hougaard, HH Parving Diabetes care 25 (5), 859-864, 2002 | 297 | 2002 |
| Urinary proteomics in diabetes and CKD K Rossing, H Mischak, M Dakna, P Zürbig, J Novak, BA Julian, DM Good, ... Journal of the American Society of Nephrology 19 (7), 1283-1290, 2008 | 296 | 2008 |
| Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial GL Bakris, R Agarwal, JC Chan, ME Cooper, RT Gansevoort, H Haller, ... Jama 314 (9), 884-894, 2015 | 295 | 2015 |
| Prevalence of arterial hypertension in diabetic patients before and after the JNC-V L Tarnow, P Rossing, MA Gall, FS Nielsen, HH Parving Diabetes care 17 (11), 1247-1251, 1994 | 273 | 1994 |
